Ingenia Therapeutics
About:
Ingenia Therapeutics is a biotechnology company developing a therapeutic antibody candidate for capillary diseases.
Website: https://ingeniatherapeutics.com
Description:
Ingenia Therapeutics is a biotechnology company developing a therapeutic antibody candidate to treat multiple diseases, including cancer and inflammatory diseases. It specializes in developing antibodies for patients suffering from defective micro-vessel and progressive chronic diseases.
Total Funding Amount:
$16.7M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Watertown, Massachusetts, United States
Founded Date:
2018-01-01
Contact Email:
info(AT)ingeniatx.com
Founders:
Sangyeul Han
Number of Employees:
1-10
Last Funding Date:
2024-06-21
IPO Status:
Private
Industries:
© 2025 bioDAO.ai